Investors & Media

SEC Filings

Document Details

Form
Filing Date
January 23, 2023
Document Date
January 19, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
COLUMN GROUP L P

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com